In conclusion, this study analyzed the differential expression, diagnostic value, prognostic value, methylation, immune infiltration and enrichment pathway of MATN3 in various cancer types using multiple databases, and MATN3 is expected to be a prognostic and immune biomarker for pan-cancer. The gene discussed is MATN3; the disease is cancer.